ARCHIVES

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

This article is from The Cancer Letter archive.

Vol. 20 No. 08 | February 25, 1994

Download PDF Visit The Full Archive

Related Articles

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

September 26, 2014

CMS Issues Coverage Decision For Provenge in Prostate Cancer

July 29, 2011

Charles Sawyers to be New AACR President-Elect

March 23, 2012

Letters to the Editor: Us Too! Objects to ODAC Member’s Comments; Brawley Responds

March 28, 2003

Byrd Permits NCI to Reallocate WVU Money

June 21, 1985

Screening Guidelines: When Scientists Can’t Agree, What’s The Press To Do?

May 15, 1998